As covered in the Wall Street Journal and other publications, Miller & Chevalier represents Robert Kramer, the former CEO of Emergent BioSolutions, in an insider trading suit filed by New York Attorney General Letitia James on January 15, 2026. As reported in the WSJ, Litigation Member Kirby Behre says the lawsuit is baseless and an overreach by James, adding that Kramer followed company policy and federal rules governing stock trading by executives. "These trading issues were reviewed by the DOJ and SEC and both chose not to pursue," Behre said. "Mr. Kramer is confident that the facts will show that this suit should never have been brought." Litigation Senior Associate Alexandria Westbrook is also assisting with the representation.